ConvaTec Group (Germany) Top Insiders

2CV Stock  EUR 2.62  0.02  0.77%   
ConvaTec Group employs about 10 K people. The company is managed by 34 executives with a total tenure of roughly 160 years, averaging almost 4.0 years of service per executive, having 294.12 employees per reported executive. Examination of ConvaTec Group's management performance can provide insight into the company performance.
Karim Bitar  CEO
Chief Executive Officer, Executive Director
John McAdam  Chairman
Independent Non-Executive Chairman of the Board
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ConvaTec Group PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation.

ConvaTec Group Management Team Effectiveness

The company has return on total asset (ROA) of 0.0643 % which means that it generated a profit of $0.0643 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.125 %, meaning that it generated $0.125 on every $100 dollars invested by stockholders. ConvaTec Group's management efficiency ratios could be used to measure how well ConvaTec Group manages its routine affairs as well as how well it operates its assets and liabilities. At this time, ConvaTec Group's Non Currrent Assets Other are most likely to increase significantly in the upcoming years.
The current Common Stock Shares Outstanding is estimated to decrease to about 2.2 B. The current Net Income Applicable To Common Shares is estimated to decrease to about 53.2 MConvaTec Group holds a total of 1.95 Billion outstanding shares. The majority of ConvaTec Group PLC outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in ConvaTec Group PLC to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in ConvaTec Group. Please pay attention to any change in the institutional holdings of ConvaTec Group PLC as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in stocks such as ConvaTec Group in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of ConvaTec Group, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

ConvaTec Group Workforce Comparison

ConvaTec Group PLC is number one stock in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 11,951. ConvaTec Group totals roughly 10,000 in number of employees claiming about 84% of equities under Health Care industry.
The company has Profit Margin (PM) of 0.09 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.15 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.15.

ConvaTec Group PLC Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. ConvaTec Group PLC Price Series Summation is a cross summation of ConvaTec Group price series and its benchmark/peer.

ConvaTec Group Notable Stakeholders

A ConvaTec Group stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as ConvaTec Group often face trade-offs trying to please all of them. ConvaTec Group's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting ConvaTec Group's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Karim BitarChief Executive Officer, Executive DirectorProfile
John McAdamIndependent Non-Executive Chairman of the BoardProfile
John LindskogPresident and Chief Operating Officer, Global Infusion CareProfile
Donal BalfeExecutive Vice President - Global Quality, Operations and RegulatoryProfile
Mani GopalPresident and Chief Operating Officer, Global Ostomy CareProfile
Supratim BosePresident and Chief Operating Officer, Global Emerging MarketsProfile
David ShepherdPresident CareProfile
Kjersti GrimsrudPresident and Chief Operating Officer, Global Continence CareProfile
David ShepherdaPresident and Chief Operating Officer, Global Advanced Wound CareProfile
MSc BiotechnologyPresident CareProfile
Fiona RyderCFO ControllerProfile
Divakar RamakrishnanChief Technology OfficerProfile
Evelyn JDEVP OfficerProfile
James KertonGeneral EVPProfile
Emma RoseEVP OfficerProfile
Frank SchulkesChief Financial Officer, Executive DirectorProfile
Christian HoengaardVP USAProfile
Heather MasonNon-Executive DirectorProfile
Adam DeutschExecutive Vice President General Counsel and Corporate DevelopmentProfile
Constantin FrengNon-Executive DirectorProfile
Sten ScheibyeNon-Executive DirectorProfile
Seth SegelPresident Home Services GroupProfile
Natalia KozminaEx OfficerProfile
Clare BatesCompany SecretaryProfile
Mark ReynoldsDirector RelationsProfile
Rick AndersonNon-Executive DirectorProfile
Margaret EwingSenior Non-Executive Independent DirectorProfile
Kate PostansVP CommunicationsProfile
Rosalind RivazNon-Executive Independent DirectorProfile
John HallerExecutive OfficerProfile
Sean McGrathExecutive Vice President - Global Human ResourcesProfile
Jonathan MasonGroup DirectorProfile
Regina BenjaminNon-Executive Independent DirectorProfile
Brian MayNon-Executive Independent DirectorProfile
String symbol = request.getParameter("s");

About ConvaTec Group Management Performance

The success or failure of an entity such as ConvaTec Group PLC often depends on how effective the management is. ConvaTec Group management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of ConvaTec management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the ConvaTec management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
ConvaTec Group Plc develops, manufactures, and markets medical products and technologies worldwide. The company was founded in 1978 and is headquartered in Reading, the United Kingdom. CONVATEC GROUP operates under Medical Instruments Supplies classification in Germany and is traded on Frankfurt Stock Exchange. It employs 9914 people.

ConvaTec Group Workforce Analysis

Traditionally, organizations such as ConvaTec Group use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare ConvaTec Group within its industry.

ConvaTec Group Manpower Efficiency

Return on ConvaTec Group Manpower

Revenue Per Employee228.9K
Revenue Per Executive67.3M
Net Income Per Employee19.1K
Net Income Per Executive5.6M
Working Capital Per Employee28.1K
Working Capital Per Executive8.3M

Complementary Tools for ConvaTec Stock analysis

When running ConvaTec Group's price analysis, check to measure ConvaTec Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ConvaTec Group is operating at the current time. Most of ConvaTec Group's value examination focuses on studying past and present price action to predict the probability of ConvaTec Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ConvaTec Group's price. Additionally, you may evaluate how the addition of ConvaTec Group to your portfolios can decrease your overall portfolio volatility.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Bonds Directory
Find actively traded corporate debentures issued by US companies
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Fundamental Analysis
View fundamental data based on most recent published financial statements
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk